Accession | ARO:3000588 |
Synonym(s) | NXL-104 |
Definition | Serine beta-lactamase inhibitor targeting class A, class C, and some class D enzymes. |
Classification | 5 ontology terms | Show |
Parent Term(s) | 29 ontology terms | Show + is_small_molecule_inhibitor TEM-1 + is_small_molecule_inhibitor TEM-3 + is_small_molecule_inhibitor TEM-9 + is_small_molecule_inhibitor TEM-10 + is_small_molecule_inhibitor TEM-12 + is_small_molecule_inhibitor TEM-26 + is_small_molecule_inhibitor TEM-28 + is_small_molecule_inhibitor TEM-71 + is_small_molecule_inhibitor SHV-1 + is_small_molecule_inhibitor SHV-2 + is_small_molecule_inhibitor SHV-3 + is_small_molecule_inhibitor SHV-4 + is_small_molecule_inhibitor SHV-7 + is_small_molecule_inhibitor SHV-18 + is_small_molecule_inhibitor SHV-52 + is_small_molecule_inhibitor OXA-1 + is_small_molecule_inhibitor ACT-1 + is_small_molecule_inhibitor CTX-M-15 + is_small_molecule_inhibitor CTX-M-24 + is_small_molecule_inhibitor CTX-M-27 + is_small_molecule_inhibitor CTX-M-55 + is_small_molecule_inhibitor CTX-M-65 + is_small_molecule_inhibitor CMY-8 + is_small_molecule_inhibitor MOX-1 + is_small_molecule_inhibitor IMP-4 + is_small_molecule_inhibitor KPC-2 + is_small_molecule_inhibitor KPC-3 + diazabicyclooctane + is_small_molecule_inhibitor MAB |
Sub-Term(s) | 3 ontology terms | Show + ceftazidime-avibactam [Antibiotic+Adjuvant] has_part + aztreonam-avibactam [Antibiotic+Adjuvant] has_part + ceftaroline-avibactam [Antibiotic+Adjuvant] has_part |
Publications | Stachyra T, et al. 2010. Antimicrob Agents Chemother 54(12): 5132-5138. Mechanistic studies of the inactivation of TEM-1 and P99 by NXL104, a novel non-beta-lactam beta-lactamase inhibitor. (PMID 20921316) Hidalgo JA, et al. 2016. Drug Des Devel Ther 10:2379-86 Ceftazidime/avibactam: a novel cephalosporin/nonbeta-lactam beta-lactamase inhibitor for the treatment of complicated urinary tract infections and complicated intra-abdominal infections. (PMID 27528799) Torrens G, et al. 2016. Antimicrob. Agents Chemother. : Activity of ceftazidime-avibactam against clinical and isogenic laboratory Pseudomonas aeruginosa isolates expressing combinations of most relevant β-lactam resistance mechanisms. (PMID 27480848) |